ABPI Compliance Policy

Print
ABPI Compliance Policy
The organizers of the '1st Meeting on Controversies in preconception, preimplantation and prenatal genetic diagnosis: How will genetics technology drive the future? (CoGEN)' recognize the ABPI Code of Practice and the implications this has for pharmaceutical companies that support the meeting.
 
ABPI compliance policy for the The '1st Meeting on Controversies in preconception, preimplantation and prenatal genetic diagnosis: How will genetics technology drive the future? (CoGEN)'
Funds generated from exhibition space and sponsorship are used solely to cover costs of the venue and logistical arrangements and do not fund any element of any social events.
 
Support from pharmaceutical companies is clearly indicated in promotional and conference materials.
 
Networking events
Evening networking events are arranged separately from the conference. They are aimed only at registered delegates and are not publicly advertised. They are funded solely by the sale of tickets to registered delegates.